Oslo, Norway

Mikkel J Gacek

This inventor holds 4 USPTO granted patents. Top assignee: Nyegaard & Co A/s. Active years: 1983-1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikkel J Gacek. Retrieved from https://idiyas.com/inventor/mikkel-j-gacek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 1983-1984

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Mikkel J. Gacek in the Field of Pyrimidine Compounds

Introduction

Mikkel J. Gacek is a prominent inventor based in Oslo, Norway. He has made significant contributions to the field of medicinal chemistry, holding a total of four patents. His innovative work primarily focuses on compounds that target abnormal cell proliferation, showcasing his commitment to advancing medical science.

Latest Patents

Gacek's latest patents include several notable innovations related to substituted pyrimid-2-ones and their derivatives. One patent details the compounds of a general formula, which includes specific configurations for substituent groups. These compounds have been found effective in combating abnormal cell proliferation. Gacek's methods involve the preparation of these compounds through the reaction of a 5-halo- or 5-trifluoromethyl-pyrimidin-2-one with an isocyanate.

Additionally, he has worked on pyrimidine-2-sulphides and their S-oxides, which also show potential in medical applications. The compounds are created through various chemical processes, including oxidation and ring closure, making them viable candidates for treating abnormal cellular growth.

Career Highlights

Mikkel Gacek's professional journey is marked by his affiliation with Nyegaard & Co. A/s, where he has been instrumental in researching and developing innovative pharmaceutical solutions. His contributions have significantly enhanced the company's portfolio and reinforced its reputation in the medicinal chemistry field.

Collaborations

Throughout his career, Gacek has collaborated with esteemed colleagues, including Kjell Undheim and Tore Benneche. These partnerships have fostered a creative and productive research environment, leading to groundbreaking discoveries in their shared field of study.

Conclusion

Mikkel J. Gacek stands out as a dedicated inventor whose work has the potential to impact the medical field significantly. His innovative patents in the realm of pyrimidine compounds illustrate his expertise and determination in the fight against abnormal cell proliferation. As the landscape of medicinal chemistry continues to evolve, Gacek's contributions will undoubtedly remain influential.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…